Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis

Shock

Volumn 8, Issue 5, 1997, Pages 349-356

  Zisman, David A ^a   Kunkel, Steven L ^a   Strieter, Robert M ^a   Gauldie, Jack ^b   Tsai, Wan C ^a   Bramson, Jonathan ^b   Wilkowski, Jodi M ^a   Bucknell, Kathy A ^a   Standiford, Theodore J ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; PRIMER DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ASCITES FLUID; BACTEREMIA; BACTERIAL COUNT; DISEASE MODEL; DRUG ANTAGONISM; ENDOTOXEMIA; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PERITONITIS; PHYSIOLOGY; SEPSIS;

ANIMALS; ASCITIC FLUID; BACTEREMIA; BASE SEQUENCE; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENDOTOXEMIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE EXPRESSION; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES, ALVEOLAR; MICE; PERITONITIS; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031264674     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199711000-00006     Document Type: Article

References (32)

1. Bone R, Fischer C, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: A valid clinical entity. Crit Care Med 17:389-393, 1989.
2. Brigham KL, Meyrick B: State of art: Endotoxin and lung injury. Am Rev Respir Dis 133:913-927, 1986.
3. Remick DG, Stricter RM, Eskandari MK, et al: Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am J Pathol 136:49-60, 1990.
4. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-γ. J Immunol 149:1666-1670, 1992.
5. Standiford TJ, Stricter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia: Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155:2222-2229, 1995.
6. Howard M, O'Garra A, Ishida H, Malefyt RD, De Vries J: Biological properties of interleukin 10. J Clin Immunol 12:239-247, 1992.
7. Brunda MJ: Interleukin-12. J Leukoc Biol 55:280-287, 1994.
8. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991.
9. Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J: The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. J Leukoc Biol 55:711-718, 1994.
10. Kobayashi M, Fitz L, Ryan M, et al: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170:827-845, 1989.
11. Heinzel FP, Schoenhaut DS, Rerko RMR, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509, 1993.
12. Gazzinelli RT, Hieny TS, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc Natl Acad Sci USA 90:6115-6119, 1993.
13. Wagner RD, Steinberg H, Brown JF, Czuprynski CJ: Recombinant interleukin-12 enhances resistance to mice to Listeria monocytogenes infection. Microb Pathog 17:175-186, 1994.
14. Flynn J, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 155:2515-2524, 1995.
15. Stevenson TJ, Tam MF, Wolfe SF, Sher A: IL-12-induced protection against blood-stage Plasmodium chabaudi requires IFN-γ and TNF-α and occurs via a nitric oxide dependent mechanism. J Immunol 155:2524-2556, 1995.
16. Metzger DW, Raeder R, Van Cleave VH, Boyle MDP: Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis 171:1643-1645, 1995.
17. Greenberger MJ, Kunkel SL, Stricter RM, et al: IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157:3006-3012, 1996.
18. Kincy-Cain T, Clements JD, Bost KL: Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun 64:1437-1440, 1996.
19. Lotze MT, Tahara H: Antitumor effects of interleukin-12 (IL12): Applications for the immunotherapy and gene therapy of cancer. Gene Therapy 2:96-106, 1995.
20. Cohen J: IL-12 deaths: Explanation and the puzzle. Science 270:908, 1995.
21. Wysocka M, Kubin M, Vieira LQ, et al: Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25:672-676, 1995.
22. Heinzel FP, Rerko RM, Ling P, Hakini J, Schoenhaut DS: Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun 62:4244-4249, 1994.
23. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL: In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 155:3546-3551, 1995.
24. Mohler KM, Torrence DS, Smith CA, et al: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561, 1993.
25. Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL: Construction and characterization of an adenovirus expressing IL-12. Hum Gene Ther 7:333-342, 1996.
26. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549, 1993.
27. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155:722-728, 1995.
28. Cassatella MA, Meda L, Gasperini A, D'Andrea A, Ma X, Trinchieri G: Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 25:1-5, 1995.
29. Perussia B, Chan SH, D'Andrea A, et al: Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on proliferation of TCR-αβ, TCR-γδ T lymphocytes, and NK cells. J Immunol 149:3495-3502, 1992.
30. Beutler B, Tkacendo V, Milsark I, Drochin N, Cerami A: Effect of interferon-γ on cachectin expression by mononuclear phagocytes. J Exp Med 17:1791-1796, 1986.
31. Ozmen L, Pericin M, Hakimi J, et al: Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J Exp Med 180:907-915, 1994.
32. Chomarat P, Rissoan M, Banchereau J, Miossec P: Interferon-γ inhibits interleukin-10 production by monocytes. J Exp Med 177:523-527, 1993.